Definium Therapeutics, Inc.

DFTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Mar 6, 2025 8-K
SCHEDULE 13G/A Feb 5, 2025
8-K Jan 30, 2025 8-K
8-K Jan 13, 2025 FORM 8-K
4 Dec 27, 2024 OWNERSHIP DOCUMENT
4 Dec 27, 2024 OWNERSHIP DOCUMENT
4 Dec 27, 2024 OWNERSHIP DOCUMENT
4 Dec 27, 2024 OWNERSHIP DOCUMENT
144 Dec 26, 2024
144 Dec 26, 2024
144 Dec 26, 2024
144 Dec 26, 2024
8-K Dec 16, 2024 8-K
4 Dec 5, 2024 4
SC 13G/A Nov 14, 2024
SC 13G Nov 8, 2024
10-Q Nov 7, 2024 10-Q
8-K Nov 7, 2024 8-K
SC 13G Oct 22, 2024
424B3 Oct 22, 2024 424B3
8-K Oct 17, 2024 FORM 8-K
424B7 Oct 17, 2024 424B7
144 Sep 25, 2024
4 Sep 25, 2024 4
4 Sep 25, 2024 4
← Newer Page 7 of 21 · 504 filings Older →